Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adenovirus CNS infections]

M Kaji1, H Shoji

  • 1First Department of Internal Medicine, University of Texas Medical Branch, USA.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Adenovirus infections commonly cause respiratory and gastrointestinal issues in infants. Central nervous system (CNS) infections from adenovirus are increasing, particularly in immunocompromised patients, posing diagnostic challenges.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).

ESMO gastrointestinal oncology·2026
Same author

Impact of travel costs on disparities in precision oncology clinical trials.

ESMO real world data and digital oncology·2026
Same author

An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma.

ESMO gastrointestinal oncology·2026
Same author

Exploring novel therapeutic targets in small bowel adenocarcinoma: insights from claudin 18.2, nectin-4, and HER3 expression analysis.

ESMO open·2025
Same author

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer.

ESMO open·2024
Same author

Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study.

ESMO open·2023

Area of Science:

  • Virology
  • Infectious Diseases
  • Neurology